Fatih Karaaslan1, Sinan Karaoğlu2, Musa Uğur Mermerkaya3, Ali Baktir4. 1. Bozok University Faculty of Medicine, Department of Orthopaedics and Traumatology, TR-66200 Yozgat, Turkey. Electronic address: Fkaraaslan@Gmail.Com. 2. Memorial Kayseri Hospital, Department of Orthopaedics and Traumatology, TR-38010 Kayseri, Turkey. 3. Bozok University Faculty of Medicine, Department of Orthopaedics and Traumatology, TR-66200 Yozgat, Turkey. 4. Modern Dünya Hospital, Department of Orthopaedics and Traumatology, TR-38010 Kayseri, Turkey.
Abstract
BACKGROUND: We asked whether tranexamic acid (TXA) administration could reduce blood loss and blood transfusion requirements after simultaneous bilateral total knee arthroplasty (TKA). This study examined the role of a novel method of TXA administration in TKA. METHODS:TXA was administered as a bolus dose of 15 mg/kg 10 min before the inflation of the tourniquet on the first side. This was followed by intra-articular administration of 3 grams at 10 min before the deflation of the tourniquet. IV infusion of 10 mg/kg/h was continued for 3h following completion on the second side. We measured volume of drained blood 48 h postoperatively, decrease in hemoglobin levels 12h postoperatively, amount of blood transfused (BT), and number of patients requiring allogenic BT. RESULTS:Median postoperative volume of drained blood was lower in the group receiving TXA (500.00 mL) than in control subjects (900.00 mL) (p <0.05) [95% CI (-525.00) to (-300.00)]. The median hemoglobin decrease 12 h postoperatively was lower in patients receiving TXA (2.10 g/dL) than in control subjects (3.10 g/dL) (p<0.05) [95% CI (-1.60) to (-0.60)]. The amount of BT and number of patients requiring BT were lower in patients receiving TXA than in control subjects. Nevertheless, the number of allogeneic units of packed red blood cells transfused in the postoperative period was not significantly higher in the control group than in the TXA group (p=0.109) [95% CI (0.101) to (0.117)]. CONCLUSIONS: This prospective randomized study showed that during simultaneous bilateral TKA, TXA reduced blood loss with negligible side effects.
RCT Entities:
BACKGROUND: We asked whether tranexamic acid (TXA) administration could reduce blood loss and blood transfusion requirements after simultaneous bilateral total knee arthroplasty (TKA). This study examined the role of a novel method of TXA administration in TKA. METHODS:TXA was administered as a bolus dose of 15 mg/kg 10 min before the inflation of the tourniquet on the first side. This was followed by intra-articular administration of 3 grams at 10 min before the deflation of the tourniquet. IV infusion of 10 mg/kg/h was continued for 3h following completion on the second side. We measured volume of drained blood 48 h postoperatively, decrease in hemoglobin levels 12h postoperatively, amount of blood transfused (BT), and number of patients requiring allogenic BT. RESULTS: Median postoperative volume of drained blood was lower in the group receiving TXA (500.00 mL) than in control subjects (900.00 mL) (p <0.05) [95% CI (-525.00) to (-300.00)]. The median hemoglobin decrease 12 h postoperatively was lower in patients receiving TXA (2.10 g/dL) than in control subjects (3.10 g/dL) (p<0.05) [95% CI (-1.60) to (-0.60)]. The amount of BT and number of patients requiring BT were lower in patients receiving TXA than in control subjects. Nevertheless, the number of allogeneic units of packed red blood cells transfused in the postoperative period was not significantly higher in the control group than in the TXA group (p=0.109) [95% CI (0.101) to (0.117)]. CONCLUSIONS: This prospective randomized study showed that during simultaneous bilateral TKA, TXA reduced blood loss with negligible side effects.
Authors: Jeffrey M Wilde; Steven N Copp; Kace A Ezzet; Adam S Rosen; Richard H Walker; Julie C McCauley; Audree S Evans; William D Bugbee Journal: Clin Orthop Relat Res Date: 2022-04-01 Impact factor: 4.176
Authors: Vasileios Soranoglou; Lazaros A Poultsides; Georgios K Triantafyllopoulos; Ivan De Martino; Stavros G Memtsoudis; Thomas P Sculco Journal: HSS J Date: 2017-12-07
Authors: Jason Tay; David Allan; Sara Beattie; Christopher Bredeson; Dean Fergusson; Dawn Maze; Mitchell Sabloff; Kednapa Thavorn; Alan Tinmouth Journal: BMJ Open Date: 2016-10-24 Impact factor: 2.692
Authors: Charles-Hervé Vacheron; Pascal Roy; Pierre Yves Petit; James Appery; Michel Fessy; Vincent Piriou; Anthony Viste; Arnaud Friggeri Journal: Indian J Orthop Date: 2020-08-24 Impact factor: 1.251
Authors: Ryan D'Souza; Christopher Duncan; Daniel Whiting; Michael Brown; Matthew Warner; Hugh Smith; Hilal Kremers; Thomas Stewart Journal: Bosn J Basic Med Sci Date: 2021-08-01 Impact factor: 3.363